dibenz[a,h]anthracene - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	dibenz[a,h]anthracene	go back to main search page
Accession:	CHEBI:35299	browse the term
Definition:	An ortho-fused polycyclic arene that has formula C22H14.
Synonyms:	related_synonym:	1,2:5,6-Dibenzanthracene; DBA; Formula=C22H14; InChI=1S/C22H14/c1-3-7-19-15(5-1)9-11-17-14-22-18(13-21(17)19)12-10-16-6-2-4-8-20(16)22/h1-14H; InChIKey=LHRCREOYAASXPZ-UHFFFAOYSA-N; SMILES=c1ccc2c(c1)ccc1cc3c(ccc4ccccc34)cc21
	alt_id:	CHEBI:18901; CHEBI:34684
	xref:	CAS:53-70-3; KEGG:C14325
	xref_mesh:	MESH:C026486

show annotations for term's descendants Sort by:
Rat (839) Mouse (897) Human (848) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (839)

dibenz[a,h]anthracene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of A2M mRNA

NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786

G

alanine and arginine rich domain containing protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AARD mRNA

NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:83,364,204...83,369,317

G

ATP binding cassette subfamily A member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCA1 mRNA

NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170

G

ATP binding cassette subfamily B member 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB1A mRNA

NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709

G

ATP-binding cassette, sub-family B member 1B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB1B mRNA

NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199

G

ATP binding cassette subfamily B member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB4 mRNA

NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202

G

ATP binding cassette subfamily C member 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ABCC3 mRNA

NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595

G

ATP binding cassette subfamily D member 3

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA

NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020

G

ATP binding cassette subfamily G member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCG5 mRNA

NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563

G

abhydrolase domain containing 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABHD15 mRNA

NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600

G

abhydrolase domain containing 5, lysophosphatidic acid acyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABHD5 mRNA

NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447

G

ABI family, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABI3 mRNA

NCBI chr10:80,769,819...80,780,816
Ensembl chr10:80,769,822...80,780,816

G

ABI family member 3 binding protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ABI3BP mRNA

NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929

G

actin-binding LIM protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABLIM1 mRNA

NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969

G

atypical chemokine receptor 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACKR4 mRNA

NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617

G

acyl-CoA thioesterase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163

G

acyl-CoA oxidase 2

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ACOX2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ACOX2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ACOX2 mRNA

NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160

G

acyl-CoA oxidase-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACOXL mRNA

NCBI chr 3:115,061,069...115,367,032
Ensembl chr 3:115,061,060...115,364,686

G

activin A receptor type 2B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ACVR2B mRNA

NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458

G

ADAM metallopeptidase domain 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAM15 mRNA

NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113

G

ADAM-like, decysin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAMDEC1 mRNA

NCBI chr15:42,900,629...42,921,684
Ensembl chr15:42,900,636...42,921,712

G

ADAMTS-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAMTSL2 mRNA

NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554

G

adenosine deaminase, tRNA-specific 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADAT3 mRNA

NCBI chr 7:9,109,070...9,113,673
Ensembl chr 7:9,101,187...9,115,340

G

adhesion G protein-coupled receptor L4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADGRL4 mRNA

NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225

G

adrenomedullin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADM mRNA

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654

G

ADP-ribosylarginine hydrolase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADPRH mRNA

NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931

G

adrenoceptor beta 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADRB1 mRNA

NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259

G

adrenoceptor beta 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADRB2 mRNA

NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512

G

apoptosis enhancing nuclease

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AEN mRNA

NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523

G

AFG1 like ATPase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AFG1L mRNA

NCBI chr20:45,798,344...45,967,997
Ensembl chr20:45,798,349...45,967,906

G

angiotensin II receptor, type 1a

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AGTR1A mRNA

NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946

G

adenosylhomocysteinase-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AHCYL2 mRNA

NCBI chr 4:58,381,290...58,531,061
Ensembl chr 4:58,381,218...58,531,060

G

aryl hydrocarbon receptor

affects response to substance
multiple interactions
affects localization
affects binding
increases activity

AHR affects the susceptibility to 1,2,5,6-dibenzanthracene
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene binds to AHR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
1,2,5,6-dibenzanthracene affects the localization of AHR protein
1,2,5,6-dibenzanthracene binds to AHR protein
1,2,5,6-dibenzanthracene results in increased activity of AHR protein
1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene affects the localization of AHR protein]

PMID:3005314 PMID:3011254 PMID:3024361 PMID:6322977 PMID:11525907 More...

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

aryl-hydrocarbon receptor repressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AHRR mRNA

NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673

G

apoptosis inducing factor, mitochondria associated 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AIFM2 mRNA

NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236

G

adenylate kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AK1 mRNA

NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041

G

adenylate kinase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AK4 mRNA

NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618

G

aldo-keto reductase family 1 member B1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of AKR1B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA

PMID:17690111 PMID:18711122

NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157

G

aldo-keto reductase family 1, member C1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AKR1C1 mRNA

NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326

G

aldolase, fructose-bisphosphate B

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ALDOB mRNA

NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116

G

alkaline phosphatase, biomineralization associated

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ALPL mRNA

NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446

G

alsin Rho guanine nucleotide exchange factor ALS2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ALS2 mRNA

NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737

G

alpha-methylacyl-CoA racemase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AMACR mRNA

NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255

G

anillin, actin binding protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ANLN mRNA

NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538

G

annexin A8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ANXA8 mRNA

NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043

G

apolipoprotein C3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of APOC3 mRNA

NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583

G

apolipoprotein D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of APOD mRNA

NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of APPL1 mRNA

NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692

G

aquaporin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AQP1 mRNA

NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690

G

androgen receptor

increases activity
multiple interactions

1,2,5,6-dibenzanthracene results in increased activity of AR protein
1,2,5,6-dibenzanthracene affects the reaction [Androgens results in increased activity of AR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AR protein

PMID:10771140 PMID:28377212 PMID:28803809

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

arginine and glutamate rich 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARGLU1 mRNA

NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349

G

Rho GTPase activating protein 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARHGAP26 mRNA

NCBI chr18:30,835,806...31,237,945
Ensembl chr18:30,838,671...31,235,194

G

Rho guanine nucleotide exchange factor 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARHGEF26 mRNA

NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819

G

ADP-ribosylation factor like GTPase 4A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARL4A mRNA

NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066

G

ADP-ribosylation factor like GTPase 4D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARL4D mRNA

NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836

G

armadillo repeat containing, X-linked 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARMCX4 mRNA

NCBI chr X:97,860,526...97,870,912
Ensembl chr X:97,860,629...97,870,912

G

arrestin domain containing 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARRDC4 mRNA

NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290

G

arylsulfatase G

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARSG mRNA

NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941

G

ADP-ribosyltransferase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ART3 mRNA

NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407

G

ADP-ribosyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ART4 mRNA

NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665

G

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASAP2 mRNA

NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975

G

anti-silencing function 1B histone chaperone

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASF1B mRNA

NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549

G

asialoglycoprotein receptor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASGR1 mRNA

NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631

G

asparagine synthetase (glutamine-hydrolyzing)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASNS mRNA

NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423

G

aspartoacylase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASPA mRNA

NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272

G

assembly factor for spindle microtubules

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASPM mRNA

NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755

G

activating transcription factor 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

activating transcription factor 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ATF5 mRNA

NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707

G

autophagy related 4C, cysteine peptidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATG4C mRNA

NCBI chr 5:113,867,218...113,935,534
Ensembl chr 5:113,867,092...113,934,830

G

ATPase Na+/K+ transporting subunit alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATP1A2 mRNA

NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544

G

aurora kinase A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AURKA mRNA

NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390

G

arginine vasopressin receptor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AVPR1A mRNA

NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215

G

beta-secretase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BACE2 mRNA

NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546

G

BAG cochaperone 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BAG3 mRNA

NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858

G

BAR/IMD domain containing adaptor protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BAIAP2 mRNA

NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134

G

basic leucine zipper ATF-like transcription factor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BATF mRNA

NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051

G

BCL2 associated X, apoptosis regulator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BAX mRNA

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

Bcl-2 binding component 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BBC3 mRNA

NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509

G

brevican

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCAN mRNA

NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460

G

Bcl2-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL2L1 mRNA

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

BCL3, transcription coactivator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCL3 mRNA

NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607

G

BCL6, transcription repressor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL6 mRNA

NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389

G

BCL6B, transcription repressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCL6B mRNA

NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974

G

BAF chromatin remodeling complex subunit BCL7C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL7C mRNA

NCBI chr 1:182,277,163...182,324,274
Ensembl chr 1:182,260,164...182,324,163

G

brain expressed, associated with NEDD4, 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BEAN1 mRNA

NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537

G

basic helix-loop-helix family, member e40

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BHLHE40 mRNA

NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774

G

bridging integrator 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BIN2 mRNA

NCBI chr 7:131,742,001...131,768,208
Ensembl chr 7:131,742,002...131,786,285

G

baculoviral IAP repeat-containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BIRC5 mRNA

NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380

G

basic helix-loop-helix ARNT like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BMAL1 mRNA

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231

G

bone morphogenetic protein receptor type 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BMPR1B mRNA

NCBI chr 2:230,538,252...230,871,077
Ensembl chr 2:230,541,558...230,871,368

G

BCL2 interacting protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BNIP3 mRNA

NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359

G

BCL2 family apoptosis regulator BOK

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BOK mRNA

NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476

G

bone marrow stromal cell antigen 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BST2 mRNA

NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979

G

BTG anti-proliferation factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BTG1 mRNA

NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649

G

complement C1q B chain

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of C1QB mRNA

NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407

G

C1q and TNF related 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF2 mRNA

NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185

G

C1q and TNF related 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF5 mRNA

NCBI chr 8:44,450,934...44,453,075
Ensembl chr 8:44,451,154...44,453,074

G

C1q and TNF related 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF7 mRNA

NCBI chr14:67,467,888...67,580,477
Ensembl chr14:67,468,014...67,580,410

G

complement C5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HC mRNA

NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994

G

carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAD mRNA

NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861

G

calcitonin receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CALCR mRNA

NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392

G

calpain 8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAPN8 mRNA

NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146

G

cell cycle associated protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAPRIN1 mRNA

NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502

G

carbonic anhydrase 3

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CA3 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of CAR3 mRNA

PMID:17690111 PMID:26377693

NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280

G

carbonic anhydrase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CAR8 mRNA

NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374

G

calcium regulated heat stable protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CARHSP1 mRNA

NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019

G

caspase 3

increases activity

1,2,5,6-dibenzanthracene results in increased activity of CASP3 protein

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

caspase 7

increases activity

1,2,5,6-dibenzanthracene results in increased activity of CASP7 protein

NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729

G

coiled-coil domain containing 162

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCDC162 mRNA

NCBI chr20:45,044,891...45,237,905
Ensembl chr20:45,032,752...45,236,193

G

coiled-coil domain containing 184

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCDC184 mRNA

NCBI chr 7:129,297,635...129,301,961
Ensembl chr 7:129,298,212...129,304,494

G

C-C motif chemokine ligand 19

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCL19 mRNA

NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308

G

CCM2 like scaffold protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCM2L mRNA

NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140

G

cellular communication network factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN1 mRNA

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cellular communication network factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN2 mRNA

NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734

G

cellular communication network factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN4 mRNA

NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248

G

cellular communication network factor 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN5 mRNA

NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636

G

cyclin A2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCNB1 mRNA

NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172

G

cyclin B2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNB2 mRNA

NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874

G

cyclin D1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCND1 mRNA

NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602

G

cyclin F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNF mRNA

NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101

G

cyclin G1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNG1 mRNA

NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641

G

cyclin J-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCNJL mRNA

NCBI chr10:27,995,682...28,053,428
Ensembl chr10:27,995,679...28,053,426

G

C-C motif chemokine receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CCR2 mRNA

NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100

G

CD151 molecule (Raph blood group)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD151 mRNA

NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753

G

CD1d1 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD1D1 mRNA

NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089

G

Cd200 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD200 mRNA

NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648

G

CD24 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD24A mRNA

NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662

G

CD34 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD34 mRNA

NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832

G

CD38 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD38 mRNA

NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986

G

Cd63 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD63 protein

NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178

G

Cd81 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD81 protein

NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660

G

cell division cycle 20

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDC20 mRNA

NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512

G

cell division cycle associated 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDCA5 mRNA

NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023

G

cell division cycle associated 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDCA8 mRNA

NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629

G

cadherin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CDH1 mRNA

NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775

G

cadherin 17

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CDH17 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CDH17 mRNA

NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884

G

cyclin-dependent kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDK1 mRNA

NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408

G

cyclin-dependent kinase inhibitor 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDKN3 mRNA

NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945

G

chromatin licensing and DNA replication factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDT1 mRNA

NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659

G

CCAAT/enhancer binding protein beta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CEBPB mRNA

NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473

G

CUGBP, Elav-like family member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CELF5 mRNA

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

cell migration inducing hyaluronidase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CEMIP2 mRNA

NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760

G

centromere protein E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CENPE mRNA

NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669

G

centromere protein K

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CENPK mRNA

NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706

G

carboxylesterase 2E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2E mRNA

NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856

G

carboxylesterase 2H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2 mRNA

NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830

G

cilia and flagella associated protein 69

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFAP69 mRNA

NCBI chr 4:28,379,604...28,452,562
Ensembl chr 4:28,375,996...28,450,698

G

complement factor D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFD mRNA

NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053

G

CASP8 and FADD-like apoptosis regulator

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFLAR mRNA

NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034

G

cell growth regulator with EF hand domain 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CGREF1 mRNA

NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852

G

chromatin assembly factor 1 subunit B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHAF1B mRNA

NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHD2 mRNA

NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502

G

choline kinase alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHKA mRNA

NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516

G

chimerin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHN2 mRNA

NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709

G

cysteine and histidine rich domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHORDC1 mRNA

NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162

G

ciliary microtubule associated protein 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CIMAP1B mRNA

NCBI chr 7:120,444,232...120,447,294
Ensembl chr 7:120,444,232...120,446,749

G

ciliary microtubule inner protein 2B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CIMIP2B mRNA

NCBI chr 5:57,675,537...57,680,133
Ensembl chr 5:57,675,462...57,678,611

G

cytokine inducible SH2-containing protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CISH mRNA

NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250

G

cytoskeleton associated protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CKAP2 mRNA

NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913

G

CDC28 protein kinase regulatory subunit 1B

affects expression

1,2,5,6-dibenzanthracene affects the expression of CKS1B mRNA

NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636

G

chloride voltage-gated channel 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLCN2 mRNA

NCBI chr11:80,197,741...80,211,657
Ensembl chr11:80,198,153...80,211,657

G

claudin 7

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CLDN7 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CLDN7 mRNA

NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171

G

claudin domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLDND1 mRNA

NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354

G

C-type lectin domain family 1, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLEC1A mRNA

NCBI chr 4:162,875,360...162,902,571
Ensembl chr 4:162,877,346...162,901,247

G

C-type lectin domain family 1, member B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLEC1B mRNA

NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291

G

C-type lectin domain family 4, member D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLEC4D mRNA

NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848

G

calmin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLMN mRNA

NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272

G

clock circadian regulator

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLOCK mRNA

NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400

G

caseinolytic mitochondrial matrix peptidase chaperone subunit X

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLPX mRNA

NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082

G

calsyntenin 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLSTN3 mRNA

NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769

G

CKLF-like MARVEL transmembrane domain containing 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CMTM4 mRNA

NCBI chr19:576,203...616,109
Ensembl chr19:576,203...616,109

G

collagen type IV alpha 1 chain

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COL4A1 mRNA

NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412

G

collagen type IV alpha 2 chain

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COL4A2 mRNA

NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839

G

collagen type V alpha 3 chain

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of COL5A3 mRNA

NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853

G

collagen like tail subunit of asymmetric acetylcholinesterase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of COLQ mRNA

NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107

G

COMM domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COMMD3 mRNA

NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177

G

coenzyme Q10B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COQ10B mRNA

NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663

G

ceruloplasmin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CP mRNA

NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075

G

carboxypeptidase E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPE mRNA

NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233

G

calcineurin-like phosphoesterase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPPED1 mRNA

NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054

G

ceramide-1-phosphate transfer protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPTP mRNA

NCBI chr 5:166,474,947...166,479,103
Ensembl chr 5:166,474,966...166,479,017

G

cellular retinoic acid binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CRABP2 mRNA

NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379

G

cAMP responsive element binding protein-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CREBL2 mRNA

NCBI chr 4:167,673,359...167,699,299
Ensembl chr 4:167,673,315...167,699,292

G

CREB/ATF bZIP transcription factor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CREBZF mRNA

NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553

G

cytokine receptor-like factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRLF2 mRNA

NCBI chr14:103,943...108,643
Ensembl chr14:103,939...108,642

G

carnitine O-octanoyltransferase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CROT mRNA

NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109

G

cryptochrome circadian regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRY2 mRNA

NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965

G

crystallin, mu

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRYM mRNA

NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633

G

colony stimulating factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CSF1 mRNA

NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704

G

catenin delta 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CTNND2 mRNA

NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764

G

C-X3-C motif chemokine ligand 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CX3CL1 mRNA

NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833

G

C-X-C motif chemokine ligand 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CXCL12 mRNA

NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168

G

cytochrome b5 type A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYB5A mRNA

NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases activity
increases expression
decreases expression
affects expression

1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; 2-oxohexyl isothiocyanate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; Cadmium Chloride inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; TP53 protein affects the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein]
[CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
CYP1A1 protein results in increased activity of 1,2,5,6-dibenzanthracene
1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [dibenzo(a,l)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; dibenzo(a,l)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; fluoranthene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]
1,2,5,6-dibenzanthracene results in decreased expression of CYP1A1 mRNA
1,2,5,6-dibenzanthracene affects the expression of CYP1A1 mRNA

PMID:8961944 PMID:10190573 PMID:11162773 PMID:11408366 PMID:11955671 More...

NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 1, subfamily a, polypeptide 2

multiple interactions
increases activity
increases metabolic processing
decreases activity
increases expression

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]
[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein
1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA

PMID:8638931 PMID:8961944 PMID:11162773 PMID:16269432 PMID:17253728 More...

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 1, subfamily b, polypeptide 1

increases expression
affects expression
multiple interactions
increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA
1,2,5,6-dibenzanthracene affects the expression of CYP1B1 mRNA
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]
1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 protein
dibenz[a,h]anthracene increases expression of CYP1B1 mRNA in lung epithelial cell

CTD
RGD

PMID:11955671 PMID:12117779 PMID:17253728 PMID:17961608 PMID:19358281 More...

NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP26B1 mRNA

NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases metabolic processing
multiple interactions

CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP2B6 mRNA; [CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol

PMID:8638931 PMID:17690111

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily d, polypeptide 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP2D6 mRNA

NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP2E1 mRNA

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 2, subfamily s, polypeptide 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP2S1 mRNA

NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303

G

cytochrome P450 family 7 subfamily B member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP7B1 mRNA

NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698

G

cystin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYS1 mRNA

NCBI chr 6:41,300,836...41,318,071
Ensembl chr 6:41,300,836...41,318,071

G

cysteine and tyrosine rich 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYYR1 mRNA

NCBI chr11:24,557,620...24,664,007
Ensembl chr11:24,515,316...24,663,961

G

dachshund family transcription factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DACH1 mRNA

NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922

G

diazepam binding inhibitor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DBI mRNA

NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693

G

D-box binding PAR bZIP transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

DDB1 and CUL4 associated factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCAF4 mRNA

NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982

G

dachsous cadherin-related 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCHS1 mRNA

NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:160,104,931...160,124,808

G

DNA cross-link repair 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCLRE1A mRNA

NCBI chr 1:255,569,911...255,589,815
Ensembl chr 1:255,569,919...255,589,678

G

dimethylarginine dimethylaminohydrolase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDAH1 mRNA

NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339

G

DNA damage-induced apoptosis suppressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDIAS mRNA

NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462

G

DNA-damage inducible transcript 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DDIT3 mRNA

NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201

G

DNA-damage-inducible transcript 4-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDIT4L mRNA

NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375

G

D-aspartate oxidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDO mRNA

NCBI chr20:44,090,823...44,109,962
Ensembl chr20:44,090,914...44,133,095

G

death effector domain containing 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DEDD2 mRNA

NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714

G

DENN domain containing 2B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DENND2B mRNA

NCBI chr 1:163,544,075...163,734,736
Ensembl chr 1:163,544,074...163,694,680

G

desumoylating isopeptidase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DESI2 mRNA

NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416

G

desert hedgehog signaling molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DHH mRNA

NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406

G

dispatched RND transporter family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DISP2 mRNA

NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800

G

dynein, axonemal, intermediate chain 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAI1 mRNA

NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925

G

dynein axonemal intermediate chain 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAI4 mRNA

NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:117,788,464...117,876,127

G

DnaJ heat shock protein family (Hsp40) member A1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAJA1 mRNA

NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967

G

DnaJ heat shock protein family (Hsp40) member B1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAJB1 mRNA

NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458

G

DNA methyltransferase 3 beta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNMT3B mRNA

NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124

G

deoxynucleotidyltransferase, terminal, interacting protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNTTIP1 mRNA

NCBI chr 3:153,481,718...153,505,403
Ensembl chr 3:153,481,705...153,505,759

G

desmoplakin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DSP mRNA

NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800

G

deltex E3 ubiquitin ligase 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DTX4 mRNA

NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818

G

dual specificity phosphatase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of DUSP1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of DUSP1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity tyrosine phosphorylation regulated kinase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DYRK3 mRNA

NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778

G

dysferlin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DYSF mRNA

NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709

G

E2F transcription factor 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of E2F7 mRNA

NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734

G

E2F transcription factor 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of E2F8 mRNA

NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098

G

endothelin converting enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ECE1 mRNA

NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371

G

extracellular matrix protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ECM1 mRNA

NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671

G

endothelin receptor type B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EDNRB mRNA

NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115

G

ephrin A1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EFNA1 mRNA

NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866

G

ephrin B2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EFNB2 mRNA

NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391

G

early growth response 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EGR1 mRNA

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of EHHADH mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of EHHADH mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of EHHADH mRNA

NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188

G

EI24, autophagy associated transmembrane protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EI24 mRNA

NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571

G

endomucin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMCN mRNA

NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929

G

EMI domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMID1 mRNA

NCBI chr14:80,000,486...80,043,561
Ensembl chr14:80,000,486...80,043,620

G

epithelial membrane protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMP1 mRNA

NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904

G

enkurin, TRPC channel interacting protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ENKUR mRNA

NCBI chr17:83,690,105...83,714,756
Ensembl chr17:83,690,797...83,714,408

G

erythrocyte membrane protein band 4.1 like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EPB41L5 mRNA

NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360

G

Eph receptor A4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EPHA4 mRNA

NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139

G

Eph receptor B6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EPHB6 mRNA

NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230

G

epoxide hydrolase 1

multiple interactions
increases expression

EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in increased expression of EPHX1 mRNA

PMID:8961944 PMID:26377693

NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235

G

erb-b2 receptor tyrosine kinase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ERBB2 mRNA

NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078

G

glutamate-rich 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ERICH3 mRNA

NCBI chr 2:243,615,777...243,717,973
Ensembl chr 2:243,615,872...243,715,317

G

endothelial cell-specific molecule 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ESM1 mRNA

NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804

G

estrogen related receptor, alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ESRRA mRNA

NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268

G

ETHE1, persulfide dioxygenase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ETHE1 mRNA

NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052

G

eva-1 homolog A, regulator of programmed cell death

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EVA1A mRNA

NCBI chr 4:114,593,773...114,643,011
Ensembl chr 4:114,593,341...114,643,011

G

exocyst complex component 3-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EXOC3L2 mRNA

NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465

G

exocyst complex component 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EXOC4 mRNA

NCBI chr 4:61,807,706...62,584,316
Ensembl chr 4:61,807,761...62,585,723

G

coagulation factor III, tissue factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of F3 mRNA

NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668

G

fatty acid binding protein 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FABP1 mRNA

NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788

G

family with sequence similarity 107, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM107A mRNA

NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396

G

family with sequence similarity 169, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM169B mRNA

NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:121,878,713...121,958,470

G

family with sequence similarity 181, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM181B mRNA

NCBI chr 1:147,166,428...147,167,925
Ensembl chr 1:147,124,740...147,168,298
Ensembl chr 1:147,124,740...147,168,298

G

family with sequence similarity 53, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM53B mRNA

NCBI chr 1:187,500,061...187,591,186
Ensembl chr 1:187,500,066...187,591,186

G

family with sequence similarity 76, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM76A mRNA

NCBI chr 5:145,107,491...145,135,734
Ensembl chr 5:145,107,491...145,135,574

G

fatty acid synthase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA

NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261

G

fibulin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FBLN1 mRNA

NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075

G

F-box protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FBXO5 mRNA

NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437

G

flap structure-specific endonuclease 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FEN1 mRNA

NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003

G

fibrinogen alpha chain

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGA mRNA

NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528

G

fibroblast growth factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGF1 mRNA

NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357

G

fibroblast growth factor 9

increases expression
increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGF9 mRNA
dibenz[a,h]anthracene increases expression of FGF9 mRNA in lung epithelial cell

CTD
RGD

PMID:19358281 PMID:19358281

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

fibroblast growth factor receptor 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGFR3 mRNA

NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341

G

fibrinogen gamma chain

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGG mRNA

NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322

G

fibrinogen-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

four and a half LIM domains 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of FHL1 mRNA

NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928

G

fin bud initiation factor homolog

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

fidgetin-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FIGNL1 mRNA

NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455

G

filamin B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FLNB mRNA

NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006

G

flavin containing dimethylaniline monoxygenase 1

affects expression

1,2,5,6-dibenzanthracene affects the expression of FMO1 mRNA

NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647

G

flavin containing dimethylaniline monoxygenase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FMO2 mRNA

NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308

G

flavin containing dimethylaniline monoxygenase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FMO3 mRNA

NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028

G

flavin containing dimethylaniline monoxygenase 5

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FMO5 mRNA

NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693

G

fibronectin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FN1 mRNA

NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678

G

forkhead box A2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FOXA2 mRNA

NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326

G

forkhead box F2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FOXF2 mRNA

NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176

G

ferric-chelate reductase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FRRS1 mRNA

NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540

G

frizzled class receptor 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FZD6 mRNA

NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776

G

glucose-6-phosphate dehydrogenase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of G6PD mRNA

NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801

G

growth arrest and DNA-damage-inducible, alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

polypeptide N-acetylgalactosaminyltransferase 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GALNT12 mRNA

NCBI chr 5:61,384,575...61,413,346
Ensembl chr 5:61,384,571...61,413,354

G

growth associated protein 43

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GAP43 mRNA

NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045

G

golgi associated RAB2 interactor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GARIN1A mRNA

NCBI chr 4:57,880,019...57,890,824
Ensembl chr 4:57,880,019...57,890,820

G

golgi associated kinase 1B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GASK1B mRNA

NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477

G

GATA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GATA2 mRNA

NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761

G

guanylate binding protein 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP4 mRNA

NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879

G

guanylate binding protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP5 mRNA

NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061

G

guanylate binding protein family member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP6 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062
Ensembl chr14:4,730,453...4,839,062

G

glucokinase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of GCK mRNA

NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995

G

growth differentiation factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GDF1 mRNA

NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,097,314...19,112,519

G

growth differentiation factor 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDF15 mRNA

NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDPD5 mRNA

NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446

G

gliomedin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GLDN mRNA

NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196

G

GLIS family zinc finger 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GLIS2 mRNA

NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578

G

G protein subunit alpha 14

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

G protein subunit alpha transducin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GNAT1 mRNA

NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671

G

golgi phosphoprotein 3-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GOLPH3L mRNA

NCBI chr 2:183,151,941...183,183,094
Ensembl chr 2:183,153,301...183,183,083

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPIHBP1 mRNA

NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702

G

G protein-coupled receptor 146

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPR146 mRNA

NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206

G

G protein-coupled receptor 162

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor, class C, group 5, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPRC5B mRNA

NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932

G

GPRIN family member 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPRIN3 mRNA

NCBI chr 4:88,572,062...88,657,369
Ensembl chr 4:88,563,607...88,657,429

G

glutathione peroxidase 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPX7 mRNA

NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004

G

growth regulating estrogen receptor binding 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GREB1 mRNA

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

gremlin 2, DAN family BMP antagonist

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GREM2 mRNA

NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615

G

gastrin releasing peptide

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GRP mRNA

NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061

G

glutathione S-transferase alpha 1

multiple interactions

GSTA1 protein affects the metabolism of and results in decreased susceptibility to 1,2,5,6-dibenzanthracene

NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121

G

glutathione S-transferase mu 1

multiple interactions

GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione]

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

glutathione S-transferase pi 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GSTP1 mRNA

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

G-2 and S-phase expressed 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GTSE1 mRNA

NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806

G

guanylate cyclase 1 soluble subunit alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GUCY1A2 mRNA

NCBI chr 8:500,212...900,201
Ensembl chr 8:500,212...889,203

G

H1.2 linker histone, cluster member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H1F2 mRNA

NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635

G

H1.5 linker histone, cluster member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H1F5 mRNA

NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160

G

H2A clustered histone 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC10 mRNA

NCBI chr17:41,570,532...41,571,020
Ensembl chr17:41,570,273...41,571,049

G

H2A clustered histone 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC12 mRNA

NCBI chr17:42,486,415...42,486,880
Ensembl chr17:42,486,415...42,486,941

G

H2A clustered histone 20

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC20 mRNA

NCBI chr 2:183,779,879...183,780,357

G

H2A clustered histone 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC4 mRNA

NCBI chr17:42,799,884...42,800,387
Ensembl chr17:42,799,652...42,800,381

G

H2A.X variant histone

increases expression

1,2,5,6-dibenzanthracene metabolite results in increased expression of H2AX protein

NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239

G

hepcidin antimicrobial peptide

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HAMP mRNA

NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891

G

hyaluronan and proteoglycan link protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HAPLN1 mRNA

NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777

G

histone deacetylase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HDAC1 mRNA

NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111

G

HEAT repeat containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HEATR1 mRNA

NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948

G

hephaestin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HEPH mRNA

NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HERC6 mRNA

NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744

G

hes-related family bHLH transcription factor with YRPW motif-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HEYL mRNA

NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152

G

Hedgehog-interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HHIP mRNA

NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528

G

HIC ZBTB transcriptional repressor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HIC1 mRNA

NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475

G

hypoxia inducible factor 1 subunit alpha

increases activity
multiple interactions

1,2,5,6-dibenzanthracene results in increased activity of HIF1A protein
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HIF1A mRNA

PMID:17690111 PMID:19502547

NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261

G

hypoxia inducible lipid droplet-associated

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HILPDA mRNA

NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557

G

histone cluster 1 H2A family member H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC11 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of H2AC22 mRNA

NCBI chr17:41,384,521...41,385,018

G

hexokinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HK1 mRNA

NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131

G

hexokinase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HKDC1 mRNA

NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867

G

HLF transcription factor, PAR bZIP family member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HLF mRNA

NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935

G

high mobility group box 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGB2 mRNA

NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140

G

high mobility group box 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGB3 mRNA

NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression
multiple interactions

1,2,5,6-dibenzanthracene results in decreased expression of HMGCR mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA

PMID:16269432 PMID:17690111

NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703

G

high mobility group nucleosomal binding domain 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGN2 mRNA

NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521
Ensembl chr16:146,192,126...146,195,521

G

histamine N-methyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HNMT mRNA

NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012

G

homer scaffold protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HOMER2 mRNA

NCBI chr 1:135,558,977...135,659,780
Ensembl chr 1:135,567,414...135,659,772

G

hook microtubule-tethering protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HOOK2 mRNA

NCBI chr19:23,151,869...23,170,139
Ensembl chr19:23,151,870...23,164,181

G

15-hydroxyprostaglandin dehydrogenase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HPGD mRNA

NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228

G

hydroxysteroid 11-beta dehydrogenase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of HSD11B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of HSD11B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HSD11B1 mRNA

NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687

G

heat shock protein family A (Hsp70) member 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPA1A mRNA

NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227

G

heat shock protein family A (Hsp70) member 4 like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPA4L mRNA

NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084

G

heat shock protein family H (Hsp110) member 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPH1 mRNA

NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224

G

hormonally upregulated Neu-associated kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HUNK mRNA

NCBI chr11:29,641,122...29,758,392
Ensembl chr11:29,640,775...29,757,526

G

Hydin, axonemal central pair apparatus protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HYDIN mRNA

NCBI chr19:38,236,996...38,583,271
Ensembl chr19:38,236,464...38,583,264

G

inhibitor of DNA binding 1

multiple interactions
increases expression

[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ID1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ID1 mRNA
1,2,5,6-dibenzanthracene results in increased expression of ID1 mRNA

PMID:18711122 PMID:26377693

NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419

G

inhibitor of DNA binding 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

immediate early response 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IER3 mRNA

NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583

G

immediate early response 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IER5 mRNA

NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227

G

interferon, alpha-inducible protein 27 like 2A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IFI27L2A mRNA

NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360

G

insulin-like growth factor 1

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of IGF1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF1 mRNA

PMID:16269432 PMID:17690111

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 1 receptor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGF1R mRNA

NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777

G

insulin-like growth factor 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF2 mRNA

NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018

G

insulin-like growth factor binding protein 1

increases expression
multiple interactions
decreases expression

1,2,5,6-dibenzanthracene results in increased expression of IGFBP1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of IGFBP1 mRNA

PMID:16269432 PMID:17690111 PMID:26377693

NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482

G

insulin-like growth factor binding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IGFBP2 mRNA

NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937

G

insulin-like growth factor binding protein 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGFBP5 mRNA

NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156

G

insulin-like growth factor binding protein 6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGFBP6 mRNA

NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966

G

IKAROS family zinc finger 4

affects expression

1,2,5,6-dibenzanthracene affects the expression of IKZF4 mRNA

NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341

G

interleukin 18 receptor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IL18R1 mRNA

NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715

G

interleukin 4 receptor

affects expression

1,2,5,6-dibenzanthracene affects the expression of IL4RA mRNA

NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980

G

inverted formin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of INF2 mRNA

NCBI chr 6:131,649,162...131,675,944
Ensembl chr 6:131,649,211...131,675,941

G

inhibin subunit beta B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of INHBB mRNA

NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832

G

inka box actin regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of INKA2 mRNA

NCBI chr 2:193,185,275...193,200,643
Ensembl chr 2:193,185,275...193,200,642

G

insulin induced gene 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of INSIG2 mRNA

NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923

G

IQ motif containing GTPase activating protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IQGAP3 mRNA

NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956

G

insulin receptor substrate 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IRS1 mRNA

NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122

G

iroquois homeobox 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IRX2 mRNA

NCBI chr 1:30,660,960...30,666,378
Ensembl chr 1:30,660,960...30,666,378

G

integrin subunit beta 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ITGB4 mRNA

NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012

G

integral membrane protein 2A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ITM2A mRNA

NCBI chr X:72,486,383...72,492,344
Ensembl chr X:72,486,381...72,492,363

G

inositol-trisphosphate 3-kinase A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ITPKA mRNA

NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600

G

jagged canonical Notch ligand 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of JAG2 mRNA

NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818

G

junctional adhesion molecule 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of JAM2 mRNA

NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063

G

joining chain of multimeric IgA and IgM

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of JCHAIN mRNA

NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298

G

KN motif and ankyrin repeat domains 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KANK4 mRNA

NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555

G

kazrin, periplakin interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KAZN mRNA

NCBI chr 5:154,392,793...155,381,567
Ensembl chr 5:154,392,793...154,779,074

G

potassium voltage-gated channel subfamily B member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNB1 mRNA

NCBI chr 3:155,820,255...155,913,383
Ensembl chr 3:155,822,963...155,916,194

G

potassium voltage-gated channel subfamily E regulatory subunit 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNE3 mRNA

NCBI chr 1:154,523,903...154,530,865
Ensembl chr 1:154,523,830...154,532,020

G

potassium calcium-activated channel subfamily N member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNN2 mRNA

NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347

G

potassium voltage-gated channel, modifier subfamily S, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNS3 mRNA

NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:33,808,216...33,865,125

G

potassium channel tetramerization domain containing 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCTD12 mRNA

NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282

G

kinesin family member 20A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF20A mRNA

NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780

G

kinesin family member 20B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF20B mRNA

NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787

G

kinesin family member 22

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF22 mRNA

NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401

G

kinesin family member 26B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KIF26B mRNA

NCBI chr13:90,282,821...90,689,058
Ensembl chr13:90,283,404...90,682,811

G

kinesin family member C1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIFC1 mRNA

NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105

G

KIT proto-oncogene receptor tyrosine kinase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KIT mRNA

NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652

G

KLF transcription factor 13

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLF13 mRNA

NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227

G

kelch-like family member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLHL5 mRNA

NCBI chr14:43,144,254...43,206,192
Ensembl chr14:43,144,257...43,184,238

G

kallikrein related-peptidase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLK8 mRNA

NCBI chr 1:94,251,803...94,258,646
Ensembl chr 1:94,251,803...94,258,646

G

kinetochore-localized astrin/SPAG5 binding protein

affects expression

1,2,5,6-dibenzanthracene affects the expression of KNSTRN mRNA

NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715

G

keratin 8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KRT8 mRNA

NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728

G

lymphocyte activating 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LAG3 mRNA

NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404

G

laminin subunit alpha 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA1 mRNA

NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478

G

laminin subunit alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA2 mRNA

NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530

G

laminin subunit alpha 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA4 mRNA

NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347

G

lipopolysaccharide binding protein

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of LBP mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of LBP mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of LBP mRNA

NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586

G

left right determination factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LEFTY1 mRNA

NCBI chr13:92,649,226...92,659,722
Ensembl chr13:92,656,323...92,659,720

G

leptin receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LEPR mRNA

NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908

G

galectin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS1 mRNA

NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345

G

galectin 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS3 mRNA

NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025

G

galectin 9

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS9 mRNA

NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045

G

galectin-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LGALSL mRNA

NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980

G

leucine-rich repeat LGI family, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGI2 mRNA

NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407

G

LIF receptor subunit alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LIFR mRNA

NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699

G

LIM domain only 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LMO2 mRNA

NCBI chr 3:90,355,234...90,377,970
Ensembl chr 3:90,365,883...90,377,953

G

ligand of numb-protein X 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LNX2 mRNA

NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494

G

lysyl oxidase-like 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LOXL4 mRNA

NCBI chr 1:241,396,183...241,416,385
Ensembl chr 1:241,397,983...241,416,322

G

lipin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LPIN1 mRNA

NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097

G

lipoprotein lipase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LPL mRNA

NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249

G

lecithin retinol acyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LRAT mRNA

NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619

G

leucine rich repeat and fibronectin type III domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LRFN3 mRNA

NCBI chr 1:85,616,862...85,623,725
Ensembl chr 1:85,616,868...85,623,725

G

leucine rich repeat containing 36

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LRRC36 mRNA

NCBI chr19:33,292,074...33,342,426
Ensembl chr19:33,292,074...33,360,141

G

leucine rich repeat containing 75B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LRRC75B mRNA

NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503

G

leukotriene B4 receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTB4R1 mRNA

NCBI chr15:29,263,199...29,265,716

G

latent transforming growth factor beta binding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTBP2 mRNA

NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208

G

leukotriene C4 synthase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTC4S mRNA

NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651

G

latexin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LXN mRNA

NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460

G

lymphocyte antigen 6 family member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LY6A mRNA

NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981

G

LysM domain containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LYSMD2 mRNA

NCBI chr 8:76,378,984...76,394,396
Ensembl chr 8:76,379,219...76,394,654

G

LysM domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LYSMD3 mRNA

NCBI chr 2:11,933,787...11,939,944
Ensembl chr 2:11,933,768...11,942,961

G

lymphatic vessel endothelial hyaluronan receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LYVE1 mRNA

NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309

G

mitotic arrest deficient 2 like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAD2L1 mRNA

NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470

G

mitotic arrest deficient 2 like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MAD2L2 mRNA

NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693

G

MAF bZIP transcription factor B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAFB mRNA

NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031

G

MAF bZIP transcription factor F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAFF mRNA

NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851

G

mitogen-activated protein kinase kinase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP2K6 mRNA

NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293

G

mitogen-activated protein kinase kinase kinase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP3K6 mRNA

NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212

G

mitogen-activated protein kinase kinase kinase kinase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP4K4 mRNA

NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698

G

microtubule-associated protein tau

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAPT mRNA

NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129

G

myristoylated alanine rich protein kinase C substrate

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MARCKS mRNA

NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012

G

MARVEL domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MARVELD1 mRNA

NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384

G

membrane bound O-acyltransferase domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MBOAT1 mRNA

NCBI chr17:34,331,413...34,445,088
Ensembl chr17:34,331,422...34,445,088

G

membrane bound O-acyltransferase domain containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MBOAT2 mRNA

NCBI chr 6:41,471,135...41,597,599
Ensembl chr 6:41,471,161...41,593,485

G

MCL1 apoptosis regulator, BCL2 family member

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MCL1 mRNA

NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303

G

minichromosome maintenance complex component 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM2 mRNA

NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847

G

minichromosome maintenance complex component 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM3 mRNA

NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314

G

minichromosome maintenance complex component 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM6 mRNA

NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960

G

MDM2 proto-oncogene

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MDM2 mRNA

NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915

G

malic enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ME1 mRNA

NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304

G

malic enzyme 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ME3 mRNA

NCBI chr 1:143,534,024...143,735,551
Ensembl chr 1:143,534,139...143,733,132

G

multiple EGF-like-domains 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MEGF6 mRNA

NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139

G

O-6-methylguanine-DNA methyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MGMT mRNA

NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756

G

matrix Gla protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MGP mRNA

NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667

G

marker of proliferation Ki-67

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MKI67 mRNA

NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762

G

MAPK interacting serine/threonine kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MKNK2 mRNA

NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827

G

melan-A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MLANA mRNA

NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343

G

monocyte to macrophage differentiation-associated 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MMD2 mRNA

NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773

G

matrix metallopeptidase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MMP8 mRNA

NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520

G

multimerin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MMRN2 mRNA

NCBI chr16:9,705,925...9,727,405
Ensembl chr16:9,705,892...9,727,405

G

meiotic nuclear divisions 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MND1 mRNA

NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096

G

MORC family CW-type zinc finger 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MORC3 mRNA

NCBI chr11:33,151,906...33,194,650
Ensembl chr11:33,152,025...33,194,646

G

MAGUK p55 scaffold protein 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MPP4 mRNA

NCBI chr 9:60,569,734...60,613,035
Ensembl chr 9:60,569,734...60,611,797

G

MPV17 mitochondrial inner membrane protein like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MPV17L mRNA

NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649

G

myelin protein zero-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MPZL1 mRNA

NCBI chr13:77,852,467...77,889,305
Ensembl chr13:77,852,467...77,896,616

G

MAS related GPR family member E

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MRGPRE mRNA

NCBI chr 1:198,963,786...198,969,862
Ensembl chr 1:198,963,787...198,969,521

G

myoregulin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MRLN mRNA

NCBI chr20:18,406,789...18,423,805
Ensembl chr20:18,406,707...18,428,418

G

mutS homolog 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MSH3 mRNA

NCBI chr 2:23,444,326...23,585,777

G

musashi RNA-binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MSI2 mRNA

NCBI chr10:73,143,760...73,510,566
Ensembl chr10:73,147,380...73,510,157

G

macrophage scavenger receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MSR1 mRNA

NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676

G

metallothionein 1, pseudogene 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MT1E mRNA

NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135

G

methylenetetrahydrofolate reductase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MTHFR mRNA

NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797

G

myotubularin related protein 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MTMR10 mRNA

NCBI chr 1:117,859,355...117,910,839
Ensembl chr 1:117,859,267...117,910,849

G

melatonin receptor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MTNR1A mRNA

NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919

G

MTSS I-BAR domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MTSS1 mRNA

NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968

G

musculoskeletal, embryonic nuclear protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MUSTN1 mRNA

NCBI chr16:6,072,908...6,075,161
Ensembl chr16:6,072,833...6,075,161

G

MYCN proto-oncogene, bHLH transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MYCN mRNA

NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590

G

nicotinamide phosphoribosyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NAMPT mRNA

NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100

G

nuclear prelamin A recognition factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NARF mRNA

NCBI chr10:106,519,508...106,537,494
Ensembl chr10:106,519,444...106,537,486

G

N-acetyltransferase 8 (GCN5-related) family member 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NAT8F5 mRNA

NCBI chr 4:118,260,323...118,285,038
Ensembl chr 4:118,260,252...118,285,704

G

non-SMC condensin I complex, subunit D2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCAPD2 mRNA

NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020

G

non-SMC condensin I complex, subunit H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCAPH mRNA

NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180

G

neutral cholesterol ester hydrolase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCEH1 mRNA

NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588

G

NDC80 kinetochore complex component

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NDC80 mRNA

NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924

G

N-myc downstream regulated 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NDRG1 mRNA

NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880

G

nectin cell adhesion molecule 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NECTIN3 mRNA

NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519

G

nestin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NES mRNA

NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777

G

neuroepithelial cell transforming 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NET1 mRNA

NCBI chr17:66,341,251...66,370,445
Ensembl chr17:66,340,728...66,370,441

G

nuclear factor, interleukin 3 regulated

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

NFKB inhibitor alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NFKBIA mRNA

NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941

G

neuronal guanine nucleotide exchange factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NGEF mRNA

NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914

G

nerve growth factor receptor

decreases expression
increases expression

1,2,5,6-dibenzanthracene results in decreased expression of NGFR mRNA
1,2,5,6-dibenzanthracene results in increased expression of TNFRSF10B mRNA

PMID:16269432 PMID:26377693

NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518

G

NHL repeat containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NHLRC2 mRNA

NCBI chr 1:255,589,743...255,648,904
Ensembl chr 1:255,589,742...255,651,408

G

NKD inhibitor of WNT signaling pathway 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NKD1 mRNA

NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380

G

nicotinamide riboside kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NMRK1 mRNA

NCBI chr 1:216,049,350...216,076,792
Ensembl chr 1:216,049,437...216,076,791

G

nitric oxide synthase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NOS3 mRNA

NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166

G

NADPH oxidase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NOX4 mRNA

NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406

G

neuropeptide Y receptor Y1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NPY1R mRNA

NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of NQO1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NQO1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NQO1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NQO1 mRNA

PMID:17253728 PMID:18711122

NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557

G

nuclear receptor subfamily 1, group D, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NR1D2 mRNA

NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553

G

nuclear receptor subfamily 5, group A, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NR5A2 mRNA

NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326

G

Notch-regulated ankyrin repeat protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRARP mRNA

NCBI chr 3:7,992,582...7,995,136
Ensembl chr 3:7,992,552...7,995,133

G

neuronal regeneration related protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NREP mRNA

NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591

G

neuregulin 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRG4 mRNA

NCBI chr 8:55,586,253...55,677,829
Ensembl chr 8:55,592,893...55,677,483

G

neurexin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRXN1 mRNA

NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710

G

NSL1 component of MIS12 kinetochore complex

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NSL1 mRNA

NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054

G

NUAK family kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NUAK2 mRNA

NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604

G

nucleoporin 58

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUP58 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUP58 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUP58 mRNA

NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060

G

nuclear protein 1, transcriptional regulator

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUPR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUPR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUPR1 mRNA

NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281

G

nucleolar and spindle associated protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NUSAP1 mRNA

NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624

G

ornithine decarboxylase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ODC1 mRNA

NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440

G

olfactomedin-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OLFML1 mRNA

NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:161,478,242...161,502,537

G

one cut homeobox 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ONECUT1 mRNA

NCBI chr 8:75,599,432...75,633,598
Ensembl chr 8:75,599,740...75,627,277

G

oxysterol binding protein-like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OSBPL5 mRNA

NCBI chr 1:198,862,071...198,916,469
Ensembl chr 1:198,862,055...198,916,469

G

otopetrin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of OTOP1 mRNA

NCBI chr14:72,505,036...72,532,497
Ensembl chr14:72,503,592...72,532,497

G

purinergic receptor P2X 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RX7 mRNA

NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619

G

purinergic receptor P2Y1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RY1 mRNA

NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457

G

purinergic receptor P2Y2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RY2 mRNA

NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632

G

phenylalanine hydroxylase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PAH mRNA

NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130

G

p21 (RAC1) activated kinase 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PAK3 mRNA

NCBI chr X:107,116,308...107,374,342
Ensembl chr X:107,260,898...107,368,314

G

palmdelphin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PALMD mRNA

NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519

G

PDZ binding kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PBK mRNA

NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014

G

protocadherin 17

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCDH17 mRNA

NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999

G

protocadherin alpha subfamily C, 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PCDHAC2 mRNA

Ensembl chr18:28,581,225...28,846,211

G

protocadherin beta 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PCDHB1 mRNA

NCBI chr18:28,913,835...28,916,746
Ensembl chr18:28,913,989...28,916,445

G

protocadherin beta 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA

NCBI chr18:29,178,869...29,183,847
Ensembl chr18:29,181,052...29,183,804

G

proliferating cell nuclear antigen

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCNA mRNA

NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995

G

Purkinje cell protein 4-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCP4L1 mRNA

NCBI chr13:83,588,992...83,612,631
Ensembl chr13:83,588,992...83,609,966

G

proprotein convertase subtilisin/kexin type 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCSK4 mRNA

NCBI chr 7:9,381,366...9,389,589
Ensembl chr 7:9,381,361...9,389,585

G

programmed cell death 6 interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDCD6IP protein

NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773

G

phosphodiesterase 8B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDE8B mRNA

NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209

G

phosphodiesterase 9A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDE9A mRNA

NCBI chr20:9,469,809...9,562,949
Ensembl chr20:9,469,848...9,562,948

G

platelet derived growth factor C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDGFC mRNA

NCBI chr 2:166,316,870...166,493,449
Ensembl chr 2:166,316,803...166,493,433

G

platelet derived growth factor D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDGFD mRNA

NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395

G

pyruvate dehydrogenase kinase 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDK4 mRNA

NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850

G

platelet and endothelial cell adhesion molecule 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PECAM1 mRNA

NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116

G

period circadian regulator 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER1 mRNA

NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431

G

period circadian regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER2 mRNA

NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459

G

period circadian regulator 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER3 mRNA

NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607

G

peroxisomal biogenesis factor 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PEX26 mRNA

NCBI chr 4:154,414,332...154,426,954
Ensembl chr 4:154,414,849...154,426,952

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PFKFB1 mRNA

NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PFKFB3 mRNA

NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125

G

pyroglutamyl-peptidase I

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PGPEP1 mRNA

NCBI chr16:18,770,563...18,782,968
Ensembl chr16:18,771,021...18,783,478

G

pleckstrin homology-like domain, family A, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PHLDA3 mRNA

NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335

G

phosphotyrosine interaction domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PID1 mRNA

NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044

G

piezo-type mechanosensitive ion channel component 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIEZO2 mRNA

NCBI chr18:56,468,449...56,844,984
Ensembl chr18:56,469,680...56,844,216

G

phosphoinositide-3-kinase regulatory subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIK3R1 mRNA

NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631

G

Pim-1 proto-oncogene, serine/threonine kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIM1 mRNA

NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174

G

PICALM interacting mitotic regulator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIMREG mRNA

NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791

G

phosphatidylinositol transfer protein, cytoplasmic 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PITPNC1 mRNA

NCBI chr10:92,163,558...92,428,971
Ensembl chr10:92,167,196...92,429,297

G

cAMP-dependent protein kinase inhibitor gamma

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKIG mRNA

NCBI chr 3:152,330,477...152,398,085
Ensembl chr 3:152,366,041...152,398,082

G

pyruvate kinase L/R

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKLR mRNA

NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870

G

protein kinase N3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKN3 mRNA

NCBI chr 3:13,350,082...13,363,572
Ensembl chr 3:13,335,041...13,363,567

G

phospholipase C, delta 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLCD4 mRNA

NCBI chr 9:76,115,523...76,158,602
Ensembl chr 9:76,117,168...76,142,453

G

phospholipase C, gamma 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLCG1 mRNA

NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330

G

phospholipase D family, member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLD6 mRNA

NCBI chr10:44,578,536...44,581,187
Ensembl chr10:44,577,675...44,581,077

G

pleckstrin homology domain containing A7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLEKHA7 mRNA

NCBI chr 1:170,364,524...170,547,843
Ensembl chr 1:170,365,135...170,547,775

G

pleckstrin homology and RhoGEF domain containing G6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLEKHG6 mRNA

NCBI chr 4:158,163,443...158,182,628
Ensembl chr 4:158,162,969...158,182,271

G

perilipin 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PLIN2 mRNA

NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319

G

polo-like kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK1 mRNA

NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400

G

polo-like kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK2 mRNA

NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947

G

polo-like kinase 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK5 mRNA

NCBI chr 7:9,346,777...9,367,923
Ensembl chr 7:9,346,777...9,355,196

G

phospholipid phosphatase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPAP2A mRNA

NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268

G

phospholipid phosphatase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLPP6 mRNA

NCBI chr 1:226,679,100...226,681,952
Ensembl chr 1:226,679,100...226,681,949

G

phorbol-12-myristate-13-acetate-induced protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PMAIP1 mRNA

NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429

G

patatin-like phospholipase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PNPLA1 mRNA

NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,917,931...6,952,375

G

proline-rich nuclear receptor coactivator 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PNRC1 mRNA

NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161

G

POC1 centriolar protein A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of POC1A mRNA

NCBI chr 8:106,922,058...106,991,678
Ensembl chr 8:106,922,978...106,991,089

G

podocalyxin-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PODXL mRNA

NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899

G

DNA polymerase epsilon, catalytic subunit

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POLE mRNA

NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939

G

DNA polymerase kappa

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POLK mRNA

NCBI chr 2:27,822,228...27,882,331
Ensembl chr 2:27,822,679...27,882,313

G

cytochrome p450 oxidoreductase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POR mRNA

NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245

G

peroxisome proliferator-activated receptor delta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPARD mRNA

NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968

G

phosphoribosyl pyrophosphate amidotransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPAT mRNA

NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144

G

pro-platelet basic protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPBP mRNA

NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130

G

periplakin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA

NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575

G

protein phosphatase, Mg2+/Mn2+ dependent, 1F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPM1F mRNA

NCBI chr11:84,064,422...84,094,410
Ensembl chr11:84,064,420...84,094,340

G

protein phosphatase 1, regulatory (inhibitor) subunit 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPP1R2 mRNA

NCBI chr11:69,472,676...69,494,468
Ensembl chr11:69,472,555...69,494,463

G

protein phosphatase 1, regulatory subunit 3C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPP1R3C mRNA

NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961

G

protein regulator of cytokinesis 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRC1 mRNA

NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765

G

prolylcarboxypeptidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRCP mRNA

NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530

G

protein C receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PROCR mRNA

NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903

G

protein S

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PROS1 mRNA

NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286

G

proline rich 36

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PRR36 mRNA

NCBI chr12:2,560,533...2,567,766
Ensembl chr12:2,560,536...2,567,742

G

proline rich and Gla domain 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRRG3 mRNA

NCBI chr X:149,666,498...149,689,353
Ensembl chr X:149,670,257...149,677,373

G

serine protease 23

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRSS23 mRNA

NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091

G

serine protease 44

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PRSS44 mRNA

NCBI chr 8:110,791,698...110,805,303
Ensembl chr 8:110,791,698...110,805,303

G

prostaglandin I2 synthase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTGIS mRNA

NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451

G

prostaglandin reductase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of PTGR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of PTGR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PTGR1 mRNA

NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666

G

protein tyrosine phosphatase 4A1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTP4A1 mRNA

NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964

G

protein tyrosine phosphatase, non-receptor type 9

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PTPN9 mRNA

NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952

G

protein tyrosine phosphatase, receptor type, G

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTPRG mRNA

NCBI chr15:12,871,706...13,552,186
Ensembl chr15:12,871,721...13,554,094

G

protein tyrosine phosphatase, receptor type, R

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTPRR mRNA

NCBI chr 7:51,662,595...51,929,605
Ensembl chr 7:51,662,595...51,929,603

G

pentraxin 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTX3 mRNA

NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323

G

peroxisomal membrane protein 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PXMP4 mRNA

NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651

G

RAB38, member RAS oncogene family

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RAB38 mRNA

NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924

G

Rac GTPase-activating protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RACGAP1 mRNA

NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831

G

RAD51 recombinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAD51 mRNA

NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035

G

RAD52 homolog, DNA repair protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAD52 mRNA

NCBI chr 4:153,106,062...153,128,598
Ensembl chr 4:153,106,062...153,128,207

G

retinoic acid early transcript 1E

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RAET1E mRNA

NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755

G

retinoic acid induced 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAI2 mRNA

NCBI chr X:32,948,656...33,011,222
Ensembl chr X:32,948,656...33,011,264

G

receptor activity modifying protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAMP3 mRNA

NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902

G

Rap guanine nucleotide exchange factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAPGEF4 mRNA

NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316

G

RASD family, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASD2 mRNA

NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016

G

RasGEF domain family, member 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RASGEF1B mRNA

NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741

G

RAS protein-specific guanine nucleotide-releasing factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASGRF2 mRNA

NCBI chr 2:23,113,613...23,361,537
Ensembl chr 2:23,117,004...23,361,240

G

RAS guanyl releasing protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASGRP3 mRNA

NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578

G

RNA binding motif protein 47

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RBM47 mRNA

NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431

G

regulator of calcineurin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RCAN1 mRNA

NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045

G

RCSD domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RCSD1 mRNA

NCBI chr13:77,901,898...77,964,309
Ensembl chr13:77,901,898...77,966,228

G

RecQ like helicase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RECQL mRNA

NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945

G

receptor accessory protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA

NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338

G

refilin B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RFLNB mRNA

NCBI chr10:60,893,693...60,899,970
Ensembl chr10:60,893,713...60,899,976

G

regulator of cell cycle

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGCC mRNA

NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141

G

regulator of G-protein signaling 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS12 mRNA

NCBI chr14:75,715,925...75,824,012
Ensembl chr14:75,715,934...75,794,596

G

regulator of G-protein signaling 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS3 mRNA

NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894

G

regulator of G-protein signaling 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS5 mRNA

NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518

G

ras homolog family member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RHOB mRNA

NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108

G

ras homolog family member C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA

PMID:22579512 PMID:26377693

NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306

G

ras homolog family member U

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RHOU mRNA

NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552

G

ribonuclease A family member 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNASE2A mRNA

NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479

G

ribonuclease H2, subunit B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNASEH2B mRNA

NCBI chr15:36,541,200...36,592,016
Ensembl chr15:36,541,218...36,584,118

G

Rho family GTPase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RND1 mRNA

NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399

G

ring finger protein 125

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF125 mRNA

NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983

G

ring finger protein 128

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF128 mRNA

NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423

G

ring finger protein 144A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF144A mRNA

NCBI chr 6:42,899,767...43,019,769
Ensembl chr 6:42,903,174...43,020,012

G

ring finger protein 167

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF167 mRNA

NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927

G

ring finger protein 169

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNF169 mRNA

NCBI chr 1:154,250,462...154,311,867
Ensembl chr 1:154,254,473...154,311,653

G

ring finger protein 186

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNF186 mRNA

NCBI chr 5:151,210,492...151,211,716
Ensembl chr 5:151,210,492...151,211,716

G

roundabout guidance receptor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ROBO2 mRNA

NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536

G

ribosomal protein L39 like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RPL39L mRNA

NCBI chr10:5,455,712...5,459,828
Ensembl chr10:5,454,559...5,462,029

G

ribosomal protein S27-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RPS27L mRNA

NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418

G

RRAD, Ras related glycolysis inhibitor and calcium channel regulator

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of RRAD mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of RRAD mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of RRAD mRNA

NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417

G

ribonucleotide reductase catalytic subunit M1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRM1 mRNA

NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261

G

ribonucleotide reductase regulatory subunit M2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRM2 mRNA

NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773

G

RRN3 homolog, RNA polymerase I transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRN3 mRNA

NCBI chr10:2,129,949...2,165,381
Ensembl chr10:2,129,978...2,165,663

G

arginine and serine rich protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RSRP1 mRNA

NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523

G

retrotransposon Gag like 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL6 mRNA

NCBI chr 7:115,684,812...115,689,897
Ensembl chr 7:115,684,739...115,690,052

G

retrotransposon Gag like 8A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL8A mRNA

NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240

G

RUN and FYVE domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RUFY3 mRNA

NCBI chr14:19,431,530...19,506,476
Ensembl chr14:19,432,524...19,507,004

G

S100 calcium binding protein A10

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of S100A10 mRNA

NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661

G

S100 calcium binding protein A14

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of S100A14 mRNA

NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:176,008,395...176,010,423

G

SAC3 domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SAC3D1 mRNA

NCBI chr 1:203,414,184...203,416,563
Ensembl chr 1:203,414,187...203,416,604

G

sterile alpha motif domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SAMD5 mRNA

NCBI chr 1:4,041,547...4,090,909
Ensembl chr 1:3,677,784...4,091,120

G

spermidine/spermine N1-acetyl transferase 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SAT1 mRNA

NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813

G

stearoyl-CoA desaturase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SCD mRNA

NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562

G

secretoglobin, family 3A, member 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SCGB3A1 mRNA

NCBI chr10:33,968,059...33,969,366
Ensembl chr10:33,968,059...33,969,476

G

sodium voltage-gated channel beta subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SCN1B mRNA

NCBI chr 1:86,353,917...86,363,820
Ensembl chr 1:86,353,917...86,363,739

G

sodium voltage-gated channel beta subunit 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SCN3B mRNA

NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868

G

signal peptide, CUB domain and EGF like domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SCUBE3 mRNA

NCBI chr20:6,199,182...6,231,100
Ensembl chr20:6,199,182...6,228,584

G

selenoprotein I

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SELENOI mRNA

NCBI chr 6:26,073,127...26,111,326
Ensembl chr 6:26,072,648...26,111,314

G

semaphorin 3C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SEMA3C mRNA

NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534

G

semaphorin 3G

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SEMA3G mRNA

NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221

G

stress-associated endoplasmic reticulum protein family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERP2 mRNA

NCBI chr15:51,879,882...51,903,958
Ensembl chr15:51,879,877...51,904,785

G

serine (or cysteine) peptidase inhibitor, clade A, member 3N

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPINA3 mRNA

NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433

G

serpin family B member 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINB1A mRNA

NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102

G

serpin family D member 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SERPIND1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SERPIND1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPIND1 mRNA

NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519

G

serpin family E member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINE1 mRNA

NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657

G

serpin family E member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINE2 mRNA

NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826

G

sestrin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SESN2 mRNA

NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260

G

shugoshin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SGO1 mRNA

NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805

G

SH3 domain containing GRB2 like 3, endophilin A3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SH3GL3 mRNA

NCBI chr 1:136,124,500...136,255,669
Ensembl chr 1:136,124,499...136,255,584

G

SHC binding and spindle associated 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SHCBP1 mRNA

NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844

G

siah E3 ubiquitin protein ligase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SIAH2 mRNA

NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950

G

SIX homeobox 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SIX1 mRNA

NCBI chr 6:91,746,739...91,751,975
Ensembl chr 6:91,746,739...91,751,975

G

spindle and kinetochore associated complex subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SKA1 mRNA

NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037

G

solute carrier family 10 member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC10A2 mRNA

NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475

G

solute carrier family 13 member 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC13A2 mRNA

NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127

G

solute carrier family 13 member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC13A4 mRNA

NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857

G

solute carrier family 16 member 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SLC16A1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SLC16A1 mRNA

NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611

G

solute carrier family 16 member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC16A5 mRNA

NCBI chr10:100,707,434...100,721,338
Ensembl chr10:100,707,434...100,721,338

G

solute carrier family 16 member 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC16A7 mRNA

NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994

G

solute carrier family 17, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC17A2 mRNA

NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325

G

solute carrier family 19 member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC19A2 mRNA

NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172

G

solute carrier family 25 member 33

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC25A33 mRNA

NCBI chr 5:160,195,040...160,219,961
Ensembl chr 5:160,195,042...160,219,961

G

solute carrier family 25, member 34

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC25A34 mRNA

NCBI chr 5:153,932,081...153,936,854

G

solute carrier family 25 member 37

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC25A37 mRNA

NCBI chr15:44,534,280...44,576,697
Ensembl chr15:44,536,727...44,577,199

G

solute carrier family 29 member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC29A4 mRNA

NCBI chr12:11,853,540...11,884,660
Ensembl chr12:11,853,540...11,874,834

G

solute carrier family 2 member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC2A1 mRNA

NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416

G

solute carrier family 2 member 9

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC2A9 mRNA

NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981

G

solute carrier family 30 member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC30A1 mRNA

NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910

G

solute carrier family 30, member 10

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC30A10 mRNA

NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103

G

solute carrier family 36 member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC36A2 mRNA

NCBI chr10:39,278,002...39,306,082
Ensembl chr10:39,278,046...39,306,082

G

solute carrier family 39 member 14

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC39A14 mRNA

NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524

G

solute carrier family 43 member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC43A1 mRNA

NCBI chr 3:69,920,586...69,946,768
Ensembl chr 3:69,920,649...69,946,768

G

solute carrier family 4 member 1 (Diego blood group)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC4A1 mRNA

NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117

G

solute carrier family 5 member 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC5A12 mRNA

NCBI chr 3:97,179,326...97,228,405
Ensembl chr 3:97,179,326...97,228,405

G

solute carrier family 5 member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC5A6 mRNA

NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712

G

solute carrier family 6 member 14

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC6A14 mRNA

NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096

G

solute carrier organic anion transporter family, member 2b1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLCO2B1 mRNA

NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353

G

SMAD family member 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SMAD3 mRNA

NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960

G

small cell adhesion glycoprotein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SMAGP mRNA

NCBI chr 7:131,720,260...131,738,711
Ensembl chr 7:131,718,740...131,738,691

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SMARCA2 mRNA

NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684

G

synuclein alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SNCA mRNA

NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262

G

synuclein, gamma

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SNCG mRNA

NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368

G

suppressor of cytokine signaling 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SOCS2 mRNA

NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548

G

sorbin and SH3 domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SORBS3 mRNA

NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758

G

SRY-box transcription factor 9

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SOX9 mRNA

NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994

G

Sp8 transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SP8 mRNA

NCBI chr 6:139,816,258...139,818,865
Ensembl chr 6:139,814,819...139,823,168
Ensembl chr 6:139,814,819...139,823,168

G

SPC25 component of NDC80 kinetochore complex

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SPC25 mRNA

NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959

G

serine peptidase inhibitor, Kunitz type 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SPINT1 mRNA

NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119

G

spondin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SPON1 mRNA

NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226

G

spondin 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SPON2 mRNA

NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996

G

secreted phosphoprotein 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPP1 mRNA

PMID:17690111 PMID:18711122

NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162

G

splA/ryanodine receptor domain and SOCS box containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SPSB1 mRNA

NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468

G

spectrin, beta, non-erythrocytic 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPTBN2 mRNA

NCBI chr 1:202,002,970...202,045,343
Ensembl chr 1:202,002,970...202,044,283

G

SLIT-ROBO Rho GTPase activating protein 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SRGAP3 mRNA

NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575

G

serglycin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SRGN mRNA

NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406

G

sarcospan

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SSPN mRNA

NCBI chr 4:178,890,030...178,946,267
Ensembl chr 4:178,897,147...178,931,554

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ST3GAL5 mRNA

NCBI chr 4:104,134,613...104,192,558
Ensembl chr 4:104,134,613...104,192,558

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ST6GALNAC4 mRNA

NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ST8SIA4 mRNA

NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:95,993,503...96,084,653

G

stabilin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of STAB2 mRNA

NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042

G

StAR-related lipid transfer domain containing 13

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of STARD13 mRNA

NCBI chr12:566,282...959,372
Ensembl chr12:566,310...959,421

G

serine/threonine kinase 35

increases expression

1,2,5,6-dibenzanthracene results in increased expression of STK35 mRNA

NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066

G

stathmin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of STMN1 mRNA

NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154

G

stathmin domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of STMND1 mRNA

NCBI chr17:18,393,312...18,420,655
Ensembl chr17:18,394,346...18,437,412

G

sulfatase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SULF2 mRNA

NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415

G

Sad1 and UNC84 domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SUN3 mRNA

NCBI chr14:83,710,136...83,748,982
Ensembl chr14:83,710,140...83,735,830

G

synaptotagmin 15

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SYT15 mRNA

NCBI chr16:9,532,478...9,543,288
Ensembl chr16:9,532,478...9,543,281

G

TGF-beta activated kinase 1/MAP3K7 binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TAB2 mRNA

NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756

G

transforming, acidic coiled-coil containing protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TACC3 mRNA

NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219

G

transporter 1, ATP binding cassette subfamily B member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TAP1 mRNA

NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901

G

threonyl-tRNA synthetase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TARS1 mRNA

NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717

G

TBC1 domain family, member 30

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TBC1D30 mRNA

NCBI chr 7:56,779,570...56,869,092
Ensembl chr 7:56,782,165...56,870,515

G

TBK1 binding protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TBKBP1 mRNA

NCBI chr10:82,120,558...82,135,749
Ensembl chr10:82,120,564...82,134,352

G

T-box transcription factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TBX4 mRNA

NCBI chr10:70,730,686...70,760,829
Ensembl chr10:70,731,163...70,760,825

G

thromboxane A2 receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TBXA2R mRNA

NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176

G

titin-cap

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TCAP mRNA

NCBI chr10:83,381,719...83,382,887
Ensembl chr10:83,381,719...83,382,887

G

trichohyalin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TCHH mRNA

NCBI chr 2:179,103,660...179,112,014
Ensembl chr 2:179,109,609...179,110,985
Ensembl chr 2:179,109,609...179,110,985

G

TEF transcription factor, PAR bZIP family member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TEF mRNA

NCBI chr 7:113,317,191...113,341,783
Ensembl chr 7:113,317,283...113,341,783

G

terminal nucleotidyltransferase 5C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TENT5C mRNA

NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744

G

tet methylcytosine dioxygenase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TET2 mRNA

NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534

G

transcription factor CP2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TFCP2 mRNA

NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939

G

transcription factor CP2-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TFCP2L1 mRNA

NCBI chr13:29,733,813...29,793,870
Ensembl chr13:29,733,840...29,793,870

G

trefoil factor 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TFF3 mRNA

NCBI chr20:9,193,259...9,197,969
Ensembl chr20:9,193,262...9,198,054

G

tissue factor pathway inhibitor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TFPI mRNA

NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880

G

transglutaminase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TGM1 mRNA

NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523

G

transglutaminase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TGM2 mRNA

NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981

G

thrombospondin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of THBS1 mRNA

NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440

G

thrombospondin 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of THBS3 mRNA

NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594

G

thyroid hormone receptor alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of THRA mRNA

NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936

G

thyroid hormone responsive

increases expression

1,2,5,6-dibenzanthracene results in increased expression of THRSP mRNA

NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075

G

thrombospondin type 1 domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of THSD1 mRNA

NCBI chr16:69,771,408...69,804,844
Ensembl chr16:69,771,408...69,801,504

G

thymocyte nuclear protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of THYN1 mRNA

NCBI chr 8:25,406,563...25,415,445
Ensembl chr 8:25,406,500...25,415,445

G

TIMP metallopeptidase inhibitor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TIMP1 mRNA

NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664

G

tubulointerstitial nephritis antigen-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TINAGL1 mRNA

NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720

G

timeless interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TIPIN mRNA

NCBI chr 8:64,780,813...64,801,358
Ensembl chr 8:64,780,828...64,801,352

G

thymidine kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TK1 mRNA

NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920

G

TLC domain containing 3B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TLCD3B mRNA

NCBI chr 1:181,421,104...181,439,744
Ensembl chr 1:181,422,830...181,439,743

G

TLC domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TLCD5 mRNA

NCBI chr 8:43,481,388...43,486,288
Ensembl chr 8:43,479,016...43,486,290

G

transmembrane 6 superfamily member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TM6SF1 mRNA

NCBI chr 1:135,799,844...135,828,515
Ensembl chr 1:135,786,381...135,828,443

G

transmembrane protein with EGF-like and two follistatin-like domains 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TMEFF2 mRNA

NCBI chr 9:50,445,947...50,733,473
Ensembl chr 9:50,436,079...50,733,475

G

transmembrane protein 171

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TMEM171 mRNA

NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:30,035,278...30,045,049

G

transmembrane protein 39a

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TMEM39A mRNA

NCBI chr11:62,160,631...62,189,964
Ensembl chr11:62,160,631...62,189,964

G

transmembrane protein 41B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TMEM41B mRNA

NCBI chr 1:164,012,585...164,026,967
Ensembl chr 1:164,012,592...164,026,933

G

transmembrane protein 88

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TMEM88 mRNA

NCBI chr10:54,118,752...54,120,447
Ensembl chr10:54,118,752...54,120,447

G

tropomodulin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TMOD2 mRNA

NCBI chr 8:76,316,736...76,366,003
Ensembl chr 8:76,325,667...76,365,720

G

transmembrane O-mannosyltransferase targeting cadherins 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TMTC1 mRNA

NCBI chr 4:181,142,937...181,357,979
Ensembl chr 4:181,146,251...181,359,289

G

transmembrane O-mannosyltransferase targeting cadherins 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TMTC2 mRNA

NCBI chr 7:40,392,377...40,806,685
Ensembl chr 7:40,394,220...40,807,298

G

TNF alpha induced protein 8 like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TNFAIP8L1 mRNA

NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254

G

TNF superfamily member 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TNFSF10 mRNA

NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135

G

tankyrase 1 binding protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TNKS1BP1 mRNA

NCBI chr 3:70,135,335...70,160,071
Ensembl chr 3:70,137,837...70,160,038

G

tumor protein p53

multiple interactions
increases response to substance

TP53 protein affects the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein]
TP53 protein results in increased susceptibility to 1,2,5,6-dibenzanthracene

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

tumor protein p53 inducible nuclear protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TRP53INP1 mRNA

NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968

G

thyroid peroxidase

increases activity

1,2,5,6-dibenzanthracene results in increased activity of TPO protein

NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199

G

TPX2, microtubule nucleation factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TPX2 mRNA

NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468

G

triggering receptor expressed on myeloid cells-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TREML1 mRNA

NCBI chr 9:12,635,584...12,642,324
Ensembl chr 9:12,635,590...12,642,347

G

tribbles pseudokinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TRIB1 mRNA

NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731

G

tribbles pseudokinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TRIB2 mRNA

NCBI chr 6:38,545,971...38,570,349
Ensembl chr 6:38,545,975...38,569,370

G

tripartite motif-containing 16

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TRIM16 mRNA

NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907

G

tripartite motif-containing 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TRIM2 mRNA

NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927

G

tripartite motif-containing 24

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TRIM24 mRNA

NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241

G

transient receptor potential cation channel, subfamily V, member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TRPV4 mRNA

NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517

G

TSC22 domain family, member 1

affects expression

1,2,5,6-dibenzanthracene affects the expression of TSC22D1 mRNA

NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958

G

TSC22 domain family, member 3

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of TSC22D3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of TSC22D3 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TSC22D3 mRNA

NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861

G

tumor susceptibility 101

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TSG101 protein

NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554

G

tsukushi, small leucine rich proteoglycan

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TSKU mRNA

NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588

G

tetraspanin 13

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TSPAN13 mRNA

NCBI chr 6:52,738,748...52,765,503
Ensembl chr 6:52,738,758...52,765,547

G

tetraspanin 18

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TSPAN18 mRNA

NCBI chr 3:79,160,060...79,299,907
Ensembl chr 3:79,161,662...79,299,852

G

tetraspanin 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TSPAN4 mRNA

NCBI chr 1:196,571,307...196,593,842
Ensembl chr 1:196,572,228...196,617,448

G

TSPY-like 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TSPYL4 mRNA

NCBI chr20:38,098,756...38,100,752
Ensembl chr20:38,098,677...38,103,053

G

tubulin tyrosine ligase like 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TTLL3 mRNA

NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:146,533,953...146,557,889

G

tubulin, beta 2A class IIa

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TUBB2A mRNA

NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714

G

tubulin, beta 5 class I

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of TUBB5 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of TUBB5 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TUBB5 mRNA

NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940

G

TUB like protein 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TULP4 mRNA

NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688

G

taxilin gamma

increases expression

1,2,5,6-dibenzanthracene results in increased expression of TXLNG mRNA

NCBI chr X:31,864,111...31,912,931
Ensembl chr X:31,864,111...31,912,926

G

thymidine phosphorylase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of TYMP mRNA

NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874
Ensembl chr 7:120,438,770...120,443,874

G

transmembrane immune signaling adaptor Tyrobp

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TYROBP mRNA

NCBI chr 1:85,672,931...85,676,856
Ensembl chr 1:85,672,994...85,676,848

G

ubiquitin D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of UBD mRNA

NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639
Ensembl chr20:1,385,864...1,408,639

G

ubiquitin-conjugating enzyme E2A

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of UBE2A mRNA

NCBI chr X:116,114,339...116,125,076
Ensembl chr X:116,113,875...116,125,070

G

ubiquitin-conjugating enzyme E2C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of UBE2C mRNA

NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339

G

ubiquitin-like 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of UBL3 mRNA

NCBI chr12:6,473,684...6,518,331
Ensembl chr12:6,473,460...6,518,862

G

UBX domain protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of UBXN1 mRNA

NCBI chr 1:205,765,309...205,769,234
Ensembl chr 1:205,745,120...205,816,520

G

UBX domain protein 11

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of UBXN11 mRNA

NCBI chr 5:146,329,666...146,353,529
Ensembl chr 5:146,329,842...146,353,526

G

UDP-glucose ceramide glucosyltransferase

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of UGCG mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of UGCG mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of UGCG mRNA

NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393

G

ubiquitin-like with PHD and ring finger domains 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of UHRF1 mRNA

NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631

G

unc-5 netrin receptor A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of UNC5A mRNA

NCBI chr17:9,614,841...9,670,558
Ensembl chr17:9,614,838...9,670,526

G

uroplakin 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of UPK1A mRNA

NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354

G

uroplakin 3A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of UPK3A mRNA

NCBI chr 7:116,128,981...116,139,950
Ensembl chr 7:116,134,874...116,139,948

G

uridine phosphorylase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of UPP2 mRNA

NCBI chr 3:43,273,048...43,317,417
Ensembl chr 3:43,273,048...43,317,417

G

ubiquinol-cytochrome c reductase binding protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of UQCRB mRNA

NCBI chr 7:63,814,784...63,820,150
Ensembl chr 7:63,814,797...63,820,150

G

ubiquitin specific peptidase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of USP2 mRNA

NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331

G

utrophin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of UTRN mRNA

NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313

G

vasorin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of VASN mRNA

NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357

G

vesicle amine transport 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of VAT1 mRNA

NCBI chr10:86,389,549...86,397,167
Ensembl chr10:86,389,545...86,397,224

G

vascular endothelial growth factor C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of VEGFC mRNA

NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848

G

vimentin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of VIM mRNA

NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187

G

vacuole membrane protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of VMP1 mRNA

NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007

G

vacuolar protein sorting 13 homolog A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of VPS13A mRNA

NCBI chr 1:213,901,999...214,128,638
Ensembl chr 1:213,901,999...214,128,555

G

VPS16 core subunit of CORVET and HOPS complexes

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of VPS16 mRNA

NCBI chr 3:117,622,534...117,644,041
Ensembl chr 3:117,622,542...117,646,441

G

von Willebrand factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of VWF mRNA

NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539

G

WD repeat domain 45

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of WDR45 mRNA

NCBI chr X:14,776,280...14,782,202
Ensembl chr X:14,776,293...14,782,202

G

WD repeat domain 62

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of WDR62 mRNA

NCBI chr 1:85,491,531...85,530,643
Ensembl chr 1:85,491,533...85,530,637

G

WD repeat domain 86

increases expression

1,2,5,6-dibenzanthracene results in increased expression of WDR86 mRNA

NCBI chr 4:10,423,496...10,443,473
Ensembl chr 4:10,424,008...10,441,465

G

WEE1 G2 checkpoint kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of WEE1 mRNA

NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688

G

WAP four-disulfide core domain 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of WFDC12 mRNA

NCBI chr 3:152,861,461...152,862,784
Ensembl chr 3:152,862,341...152,862,690

G

WAS/WASL interacting protein family, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of WIPF3 mRNA

NCBI chr 4:83,550,075...83,629,929
Ensembl chr 4:83,550,468...83,629,386

G

Wnt family member 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of WNT1 mRNA

NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651

G

X-box binding protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of XBP1 mRNA

NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693

G

X-prolyl aminopeptidase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of XPNPEP2 mRNA

NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223

G

Z-DNA binding protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZBP1 mRNA

NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870

G

zinc finger and BTB domain containing 16

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZBTB16 mRNA

NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011

G

zinc finger and BTB domain containing 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ZBTB5 mRNA

NCBI chr 5:59,244,132...59,265,461
Ensembl chr 5:59,243,307...59,265,426

G

zinc finger CCHC-type containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZCCHC2 mRNA

NCBI chr13:22,118,677...22,193,626
Ensembl chr13:22,119,568...22,166,373

G

zinc finger DHHC-type palmitoyltransferase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZDHHC2 mRNA

NCBI chr16:51,808,465...51,878,060
Ensembl chr16:51,808,468...51,878,060

G

zinc finger DHHC-type palmitoyltransferase 22

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ZDHHC22 mRNA

NCBI chr 6:106,629,090...106,646,996
Ensembl chr 6:106,631,609...106,638,872

G

zinc finger protein 365

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP365 mRNA

NCBI chr20:20,666,240...20,689,734
Ensembl chr20:20,666,240...20,691,238

G

zinc finger protein 385B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP385B mRNA

NCBI chr 3:62,355,182...62,640,417
Ensembl chr 3:62,355,196...62,640,510

G

zinc finger protein 423

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP423 mRNA

NCBI chr19:19,111,213...19,407,373
Ensembl chr19:19,110,238...19,407,373

G

zinc finger protein 445

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP445 mRNA

NCBI chr 8:122,453,175...122,473,355
Ensembl chr 8:122,454,328...122,473,286

G

zinc finger protein 503

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP503 mRNA

NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848

G

zinc finger protein 521

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP521 mRNA

NCBI chr18:4,775,952...5,068,592
Ensembl chr18:4,787,295...5,068,458

G

zinc finger protein 536

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ZFP536 mRNA

NCBI chr 1:90,000,359...90,463,423
Ensembl chr 1:90,002,858...90,462,990

G

zinc finger protein 612

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZFP612 mRNA

NCBI chr19:38,053,953...38,071,196
Ensembl chr19:38,053,967...38,067,455

G

zinc finger, matrin type 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZMAT3 mRNA

NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863

G

zinc finger, MYND-type containing 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ZMYND15 mRNA

NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	19808
role	19784
biological role	19782
aetiopathogenetic role	19166
genotoxin	17649
mutagen	17569
dibenz[a,h]anthracene	839
Path 2
Term	Annotations
CHEBI ontology	19808
subatomic particle	19806
composite particle	19806
hadron	19806
baryon	19806
nucleon	19806
atomic nucleus	19806
atom	19806
main group element atom	19756
main group molecular entity	19756
s-block molecular entity	19595
hydrogen molecular entity	19582
hydrides	19095
organic hydride	18669
organic fundamental parent	18669
hydrocarbon	18415
cyclic hydrocarbon	17215
arene	17195
polycyclic arene	17023
ortho-fused polycyclic arene	9806
dibenz[a,h]anthracene	839

paths to the root